Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety
Authors:
Open Access
- 1 November 1998
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 44 (9) , 812-824
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Double-blind, placebo-controlled study of once daily venlafaxine XR In outpatients with generalized anxiety disorderEuropean Neuropsychopharmacology, 1998
- P.3.055 Fluoxetine in panic disorder: A placebo-controlled studyEuropean Neuropsychopharmacology, 1997
- Double-blind flexible dose study of sertraline and placebo in patients with panic disorderEuropean Neuropsychopharmacology, 1996
- Sertraline in Social PhobiaJournal of Clinical Psychopharmacology, 1995
- Neurotransmitters in the CNS control of breathingRespiration Physiology, 1995
- Fluoxetine in Social PhobiaJournal of Clinical Psychopharmacology, 1992
- High-affinity platelet [3H]LSD binding is decreased in panic disorderJournal of Affective Disorders, 1990
- Serotonin in Panic DisorderInternational Clinical Psychopharmacology, 1989
- Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmissionTrends in Pharmacological Sciences, 1987
- Effect of Serotonin Uptake Inhibitors in Anxiety Disorders; a Double-blind Comparison of Clomipramine and FluvoxamineInternational Clinical Psychopharmacology, 1987